194 related articles for article (PubMed ID: 37442189)
21. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
22. A Systematic Analysis of Dysregulated Long Non-Coding RNAs/microRNAs/mRNAs in Lung Squamous Cell Carcinoma.
Zhang TJ; Cao JS; Li Q; An GS; Ni JH; Jia HT; Li SY
Am J Med Sci; 2020 Dec; 360(6):701-710. PubMed ID: 33012486
[TBL] [Abstract][Full Text] [Related]
23. Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer.
Wu J; Luo D; Li S
Breast Cancer (Dove Med Press); 2020; 12():267-277. PubMed ID: 33324095
[TBL] [Abstract][Full Text] [Related]
24. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of
Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q
Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154
[TBL] [Abstract][Full Text] [Related]
25. Network pharmacology and bioinformatics analysis on the underlying mechanisms of baicalein against oral squamous cell carcinoma.
Tang B; Dong Y
J Gene Med; 2023 Jun; 25(6):e3490. PubMed ID: 36843559
[TBL] [Abstract][Full Text] [Related]
26. Identification of potential diagnostic and therapeutic target genes for lung squamous cell carcinoma.
Zhang N; Wang H; Xie Q; Cao H; Wu F; Di Wu DB; Wan Y
Oncol Lett; 2019 Jul; 18(1):169-180. PubMed ID: 31289486
[TBL] [Abstract][Full Text] [Related]
27. LINC01936 inhibits the proliferation and metastasis of lung squamous cell carcinoma probably by EMT signaling and immune infiltration.
Tian Q; Liu X; Li A; Wu H; Xie Y; Zhang H; Wu F; Chen Y; Bai C; Zhang X
PeerJ; 2023; 11():e16447. PubMed ID: 38084139
[TBL] [Abstract][Full Text] [Related]
28. Prediction of network pharmacology and molecular docking-based strategy to determine potential pharmacological mechanism of Liuwei Dihuang pill against tinnitus.
Wu Z; Zhu Z; Cao J; Wu W; Hu S; Deng C; Xie Q; Huang X; You C
Medicine (Baltimore); 2022 Nov; 101(46):e31711. PubMed ID: 36401375
[TBL] [Abstract][Full Text] [Related]
29. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Taxus chinensis against non-small cell lung cancer.
Zhang S; Wang J; Zhang H
Medicine (Baltimore); 2023 Nov; 102(44):e35826. PubMed ID: 37933017
[TBL] [Abstract][Full Text] [Related]
30. Desmoglein 3 and Keratin 14 for Distinguishing Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Dong Y; Li S; Sun X; Wang Y; Lu T; Wo Y; Leng X; Kong D; Jiao W
Onco Targets Ther; 2020; 13():11111-11124. PubMed ID: 33149622
[TBL] [Abstract][Full Text] [Related]
31. Effect of Cepharanthine on the Stemness of Lung Squamous Cell Carcinoma Based on Network Pharmacology and Bioinformatics.
Liu B; Deng JX
Biomed Res Int; 2022; 2022():5956526. PubMed ID: 36483630
[TBL] [Abstract][Full Text] [Related]
32. Identification of tumor-suppressor genes in lung squamous cell carcinoma through integrated bioinformatics analyses.
Li H; Lei Y; Li G; Huang Y
Oncol Res; 2023; 32(1):187-197. PubMed ID: 38188687
[TBL] [Abstract][Full Text] [Related]
33. Screening and identification of key biomarkers in lung squamous cell carcinoma by bioinformatics analysis.
Man J; Zhang X; Dong H; Li S; Yu X; Meng L; Gu X; Yan H; Cui J; Lai Y
Oncol Lett; 2019 Nov; 18(5):5185-5196. PubMed ID: 31612029
[TBL] [Abstract][Full Text] [Related]
34. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
35. Identification and validation of key genes associated with non-small-cell lung cancer.
Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
[TBL] [Abstract][Full Text] [Related]
36. Identification of a cancer-associated fibroblast classifier for predicting prognosis and therapeutic response in lung squamous cell carcinoma.
Lai X; Fu G; Du H; Xie Z; Lin S; Li Q; Lin K
Medicine (Baltimore); 2023 Sep; 102(38):e35005. PubMed ID: 37746966
[TBL] [Abstract][Full Text] [Related]
37. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
Yu H; Pang Z; Li G; Gu T
J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
[TBL] [Abstract][Full Text] [Related]
38. A network pharmacology and bioinformatics exploration of the possible molecular mechanisms of Fuzheng Xiaoliu Granule for the treatment of hepatocellular carcinoma.
Fan T; Chen X; Yang F; Li Y; Gao Q; Li S; Chen X; Chen X
J Clin Transl Res; 2023 Jun; 9(3):182-194. PubMed ID: 37275579
[TBL] [Abstract][Full Text] [Related]
39. Network Pharmacology-based Strategy to Investigate Pharmacological Mechanisms of Qingbutongluo Pill for Treatment of Brucellosis.
Wang J; He JW; Liu JS; Li JE; Cui QY; Wang YR; Zhou WG
Comb Chem High Throughput Screen; 2023; 26(4):706-718. PubMed ID: 35692141
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of Glycitein in the Treatment of Colon Cancer Based on Network Pharmacology and Molecular Docking.
Xiang T; Jin W
Lifestyle Genom; 2023; 16(1):1-10. PubMed ID: 36183698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
